Jan29
Grand Rounds
Intracochlear administration of DB-OTO Gene Therapy in pediatric patients with profound hearing loss due to otoferlin mutations: the CHORD Phase 1 / 2 open-label trial
OHNS Grand Rounds - Eduardo Corrales, MD